2020-11-16T16:59:05-06:00 2019-12-31 721473527 HIENZ & MACALUSO LLC 110 VETERANS BLVD SUITE 170 METAIRIE LA 70005 990 2019-01-01 471643994 ANSWER ALS ANSW 8004902375 ONE GALLERIA BLVD NO 1100 METAIRIE LA 70001 PAUL VARISCO DIRECTOR 8004902375 2020-11-16 1 ANTHONY MACALUSO P00751263 5048375434 2020-11-16 104.4.213.241 2020-11-16 16:46:25 CS P 59D754DDD91289B0FA5EE6D788F55277DE04D053 59D754DDD91289B0FA5EE6D788F55277DE04D053 2019 2021-01-29 14:40:06Z PAUL VARISCO ONE GALLERIA BLVD NO 1100 METAIRIE LA 70001 1674196 0 X WWW.ANSWERALS.ORG X 2014 LA TO FIND SOLUTIONS FOR PEOPLE LIVING WITH ALS NOW AND FOR THE FUTURE BY UTILIZING KNOWLEDGE OF PATIENTS, LEADING RESEARCHERS AND TECHNOLOGY TO SEEK IMMEDIATE SOLUTIONS TO IMPROVE THE LIVES OF THOSE LIVING WITH ALS UNTIL A TREATMENT OR CURE IS FOUND; DISCOVER WHAT CAUSES ALS; DEVELOP MODELS TO UNDERSTAND ALS AND SCREEN FOR DRUG AND CELLULAR THERAPY; DISCOVER THERAPIES THAT COULD SUBSTANTIALLY SLOW OR HALT THE PROGRESS OF ALS AND ULTIMATELY CURE THE DISEASE; PROVIDE ALL GATHERED INFORMATION FREE FOR WORLDWIDE USE BY CLINICIANS, SCIENTISTS AND PHARMA TO RAPIDLY ADVANCE THERAPEUTICS. 11 8 1 25 0 0 6826026 1559568 0 0 0 0 1579845 -198979 8405871 1360589 1500000 2077600 0 0 0 35516 0 0 84701 156771 223523 1656771 2336639 6749100 -976050 9195404 8202383 451928 434957 8743476 7767426 X TO FIND SOLUTIONS FOR PEOPLE LIVING WITH ALS NOW AND FOR THE FUTURE BY UTILIZING KNOWLEDGE OF PATIENTS, LEADING RESEARCHERS AND TECHNOLOGY TO SEEK IMMEDIATE SOLUTIONS TO IMPROVE THE LIVES OF THOSE LIVING WITH ALS UNTIL A TREATMENT OR CURE IS FOUND; DISCOVER WHAT CAUSES ALS; DEVELOP MODELS TO UNDERSTAND ALS AND SCREEN FOR DRUG AND CELLULAR THERAPY; DISCOVER THERAPIES THAT COULD SUBSTANTIALLY SLOW OR HALT THE PROGRESS OF ALS AND ULTIMATELY CURE THE DISEASE; PROVIDE ALL GATHERED INFORMATION FREE FOR WORLDWIDE USE BY CLINICIANS, SCIENTISTS AND PHARMA TO RAPIDLY ADVANCE THERAPEUTICS. 0 0 2212535 2077600 CREATING THE LARGEST AND MOST COMPREHENSIVE FOUNDATION OF ALS DATA EVER AMASSED, ENCOMPANSING CLINICAL, CHEMICAL, GENETIC, PROTEIN, HISTORICAL AND BIOLOGICAL DATA FROM AN ENORMOUS SAMPLING OF ALS PATIENTS IN THE UNITED STATES. IN COLLABORATION WITH MACHINE LEARNING AND BIG DATA TECHNOLOGY, THE DATA WILL BE MINED TO UNCOVER ALS CAUSES, SUBTYPES, PATHWAYS GONE AWRY AND DRUG TARGETS. THIS WILL ESTABLISH A LARGE AND CRITICAL FOUNDATION FOR NEW CLINICAL TRIALS, DEVELOP NEW WAYS TO CATEGORIZE PATIENTS TO IDENTIFY SPECIFIC DRUGGABLE PATHWAYS AND SUBTYPE BIOMARKERS AND DISEASE PATHOPHYSIOLOGY TO AID NOT ONLY IN EARLY DIAGNOSIS OF THE DISEASE, BUT ALSO TO MONITOR THE EFFICACY OF NEWLY DEVELOPED TREATMENTS. 2212535 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 4 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 11 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X LIZ HATCH ACCOUNTING 5043096393 190 E OAKRIDGE PARK METAIRIE LA 70005 X BEVERLY GOULET CHAIRMAN & DIRECTOR 1.00 X X 0 0 0 THOMAS CAPELLA TREASURER 2.00 X X 0 0 0 CLARE DURRETT BOARD MEMBER/MANAGING COORDINATOR 20.00 X X 0 0 0 STEVE GLEASON BOARD MEMBER 1.00 X 0 0 0 PAUL VARISCO BOARD MEMBER/CO-COORDINATOR 5.00 X X 0 0 0 DAVID SHERMAN SECRETARY 1.00 X X 0 0 0 MICHELLE FARR BOARD MEMBER 1.00 X 0 0 0 STEVE FINKBEINER BOARD MEMBER 1.00 X 0 0 0 GIANUGO RABELLINO BOARD MEMBER 1.00 X 0 0 0 JAY QUINLAN BOARD MEMBER 1.00 X 0 0 0 PATRICK QUINN BOARD MEMBER 1.00 X 0 0 0 0 0 0 0 0 0 0 0 1022380 537188 1559568 114628 1022380 313607 -198979 -198979 1360589 0 0 -198979 2077600 2077600 32308 18462 13846 3208 1724 1484 13034 13034 36000 36000 2101 1496 15 590 4365 224 4021 120 5395 2064 243 3088 20220 9222 53 10945 3330 3330 17233 12063 5170 6692 6692 VIDEO AND PHOTOGRAPHY 59074 0 0 59074 BAD DEBT EXPENSE 43600 43600 0 0 MISCELLANEOUS 4457 1067 15 3375 WEBSITE MAINTENANCE 3819 3519 0 300 4203 2164 2039 2336639 2212535 39403 84701 7053184 7125474 1900000 950000 210626 23626 88922 31594 14361 9195404 8202383 250998 74957 200930 360000 451928 434957 X 6843476 6817426 1900000 950000 8743476 7767426 9195404 8202383 -976050 0 X 0 1 X 0 0 X 440835 1142342 1877678 6826026 537188 10824069 440835 1142342 1877678 6826026 537188 10824069 4438325 6385744 285 868576 3318969 4187830 15011899 0.42540 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DEFERRED REVENUE 360000 360000 X 1368389 7800 7800 1360589 0 1360589 2344439 7800 7800 2336639 0 2336639 PART X, LINE 2: ACCOUNTING STANDARDS PROVIDE DETAILED GUIDANCE FOR FINANCIAL STATEMENT RECOGNITION, MEASUREMENT AND DISCLOSURE OF UNCERTAIN TAX POSITIONS RECOGNIZED IN AN ENTITY'S FINANCIAL STATEMENTS.AS OF DECEMBER 31, 2018, MANAGEMENT OF THE ORGANIZATION BELIEVES THAT IT HAS NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. GOLF TOURNAMENT 1114795 1022380 92415 10419 173847 125977 3364 1 22213 22213 1137008 1022380 114628 10419 173847 125977 3364 313607 -198979 0 ROBERT PACKARD CENTER FOR ALS RESEARCH JOHN HOPKINS UNIVERSITY SCHOOL OF ME 855 NORTH WOLFE STREET RM 270 BALTIMORE MD 21205 2000000 DONATION TO ALS RESEARCH. EVERGREEN CIRCUITS LLC 14023 284TH CIR NE DUVALL WA 98019 77600 APPLICATION TO ASSIST ALS PATIENTS DRIVE THEIR WHEELCHAIRS WITH THEIR EYES. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE ORGANIZATION'S FORM 990 WILL BE PROVIDED TO THE ORGANIZATION'S GOVERNING BODY FOR REVIEW PRIOR TO IT BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD REVIEWS AND ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION C, LINE 18 FORM 1023 IS AVAILABLE UPON REQUEST. FORM 990, PART VI, SECTION C, LINE 19 NO DOCUMENTS ARE PROVIDED TO THE GENERAL PUBLIC. GLEASON INITIATIVE FOUNDATION PO BOX 24493 NEW ORLEANS LA 70124 453689316 SEE PART VII EXPLANATION LA 501(C)(3) LINE 7 N/A 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 GLEASON INITIATIVE FOUNDATION B 198528 FMV